- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Deer Park Today
By the People, for the People
Eton Pharmaceuticals to Attend Leerink Partners Healthcare Conference
The pharmaceutical company will host one-on-one meetings at the event in Miami.
Published on Feb. 28, 2026
Got story updates? Submit your updates here. ›
Eton Pharmaceuticals, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that members of its executive leadership team will host one-on-one meetings at the Leerink Partners Global Healthcare Conference on Wednesday, March 11, 2026 in Miami, Florida.
Why it matters
Eton Pharmaceuticals is a growing player in the rare disease pharmaceutical market, with eight commercial products and four additional late-stage product candidates. Attending industry conferences like the Leerink Partners event allows the company to connect with potential investors, partners, and customers to drive awareness and growth.
The details
Eton Pharmaceuticals currently has eight commercial rare disease products, including KHINDIVI, INCRELEX, ALKINDI SPRINKLE, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The company also has four additional product candidates in late-stage development: Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
- The Leerink Partners Global Healthcare Conference will take place on Wednesday, March 11, 2026 in Miami, Florida.
The players
Eton Pharmaceuticals
An innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.
The takeaway
Eton Pharmaceuticals' participation in the Leerink Partners conference demonstrates its commitment to expanding its rare disease drug portfolio and building relationships within the healthcare industry.
